General

Showing 2273–2288 of 2309 results

• 

  Article: Vaccine response in patients receiving anti-B-cell targeted therapy

  €3.03 Add to cart
• 

  Article: Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS syndrome) with multiple thromboembolism events: A Belgian case report

  €3.03 Add to cart
• 

  Article: Validation of a ready to use Clauss fibrinogen

  €3.03 Add to cart
• 

  Article: Value and implications of the anti-Xa activity monitoring in pregnant women receiving prophylactic LMWH: a retrospective study

  €3.03 Add to cart
• 

  Article: Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia

  €3.03 Add to cart
• 

  Article: Venetoclax-Azacitidine, the new standard of care for AML patients unfit for intensive treatment: A guide for clinical practice

  €3.03 Add to cart
• 

  Article: Venetoclax-rituximab induces deep responses in relapsed CLL

  €3.03 Add to cart
• 

  Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

  €3.03 Add to cart
• 

  Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

  €3.03 Add to cart
• 

  Article: VENOUS THROMBOEMBOLISM

  €3.03 Add to cart
• 

  Article: VEXAS Syndrome: Current knowledge and management strategies

  €3.03 Add to cart
• 

  Article: VEXAS-syndrome: A state of the art

  €3.03 Add to cart
• 

  Article: Volume 6, Issue 1, February 2012

  €3.03 Add to cart
• 

  Article: Von Willebrand factor and ADAMTS13: new players in ischemia/reperfusion injury

  €3.03 Add to cart
• 

  Article: VON WILLEBRAND FACTOR: A NEW FLOW MARKER IN CARDIOVASCULAR PATHOLOGY

  €3.03 Add to cart
• 

  Article: Waldenstrom’s macroglobulinaemia: Belgian Hematology Society guidelines

  €3.03 Add to cart